Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05852938 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05852938 · ClinicalTrials.gov record · last posted 2026-04-01

A Study of Zigakibart in Adults With IgA Nephropathy

StatusActive, Not Recruiting
PhasePhase 3
Started2023-07-06
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy

Amendment record 15 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 15 times since 2023-05-02; most recent amendment 2026-03-27. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-08-12
Status change Recruiting→Active, Not Recruitingv11
2023-07-12
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05852938
Lead Sponsor Novartis Pharmaceuticals
Conditions IgA Nephropathy, Immunoglobulin A Nephropathy
Enrollment 383 participants
Start Date 2023-07-06
Primary Completion 2027-08-10 (estimated)
Study Completion 2028-01-25 (estimated)
Updated on ClinicalTrials.gov 2026-04-01